Myocardial Infarction, Acute Clinical Trial
Official title:
Effect of INtravenous FERRic Carboxymaltose Onmortality and Cardiovascular Morbidity, and Quality of Life in Iron Deficient Patients With Recent Myocardial infarCTion SUBTITLE Prevention of Cardiovascular Death, Heart Failure Events and Deterioration in Quality of Life With INtravenous FERRic Carboxymaltose in Iron Deficient Patients With Recent Myocardial Infarction
Non-commercial, multicentre, randomised, double-blind, parallel group, placebo-controlled clinical trial. Eligible patients were randomly assigned (1:1) using a secure, central, interactive, web-based response system, to intervention FCM or placebo arm. Time of observation 12 months [12 main study + 3 years follow up in substudy B]. Primary Study Objective: Primary: Evaluation of the effect of i.v. FCM treatment compared with placebo on the risk of cardiovascular (CV) death, the risk of heart failure events (HFE*) (number of events and time to first event) during the 12-month follow-up and the change in quality of life (QoL) assessed using EQ-5D during the 8-month follow-up in patients with recent AMI and ID (with an implementation of a win ratio approach in a hierarchical descending order). *HFE: unplanned hospitalization for HF (including unplanned visit at emergency department due to HF), ambulatory significant intensification of diuretic therapy (either starting i.v. loop diuretic or more than doubling oral loop diuretic dose or de novo initiation of oral loop diuretic therapy due to HF signs/symptoms).
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06038994 -
Prognostic Value of Surem TRAF3IP2 Level in Patients With Acute Myocardial Infarction
|
||
| Recruiting |
NCT04968808 -
Timing of FFR-guided PCI for Non-IRA in NSTEMI and MVD (OPTION-NSTEMI)
|
N/A | |
| Completed |
NCT03338504 -
Determining the Mechanism of Myocardial Injury and Role of Coronary Disease in Type 2 Myocardial Infarction
|
||
| Recruiting |
NCT03317691 -
The ALERT-Pilot Study
|
N/A | |
| Active, not recruiting |
NCT05077683 -
Direct Oral Anticoagulants for Prevention of lEft ventRIcular Thrombus After Anterior Acute Myocardial InFarction - APERITIF
|
Phase 3 | |
| Recruiting |
NCT03957005 -
Cardiovascular Risk Assessment Model in Patients With MI
|
||
| Enrolling by invitation |
NCT05955950 -
Gratitude Intervention in Promoting Self-care in Patients With Myocardial Infarction
|
N/A | |
| Active, not recruiting |
NCT06141252 -
Benefit of Hypothermia in OHCA Complicating AMI
|
N/A | |
| Not yet recruiting |
NCT04560023 -
Effectiveness of Multimedia Exposure in Patients Transferred to Hospital Suffering From Acute Myocardial Infarction
|
N/A | |
| Recruiting |
NCT03809689 -
Study of Cardiac Lesions Angiogenesis by 68Ga-NODAGA-RGD Cardiac PET
|
N/A | |
| Completed |
NCT05118009 -
Artificial Intelligence Based Rapid Identification of ST-elevation Myocardial Infarction Using Electrocardiogram (ARISE)
|
N/A | |
| Active, not recruiting |
NCT04753749 -
Evaluation of a Modified Anti-Platelet Therapy Associated With Low-dose DES Firehawk in Acute Myocardial Infarction Patients Treated With Complete Revascularization Strategy
|
N/A | |
| Completed |
NCT04769219 -
Secondary Prevention Education After Acute Myocardial Infarction
|
N/A | |
| Active, not recruiting |
NCT05350969 -
Study to Assess Efficacy and Safety of CDR132L in Patients With Reduced Left Ventricular Ejection Fraction After Myocardial Infarction
|
Phase 2 | |
| Recruiting |
NCT05999110 -
Algarve Active Ageing - Cardiac and Osteoarthritis Rehabilitation (A3-COR)
|
N/A | |
| Completed |
NCT04167904 -
Biomarkers in Patients Hospitalized With Suspected Acute Myocardial Infarction
|
||
| Not yet recruiting |
NCT04989777 -
IABP In AMI Patients With SCAI-B Study
|
N/A | |
| Recruiting |
NCT05043610 -
MSCs for Prevention of MI-induced HF
|
Phase 3 | |
| Recruiting |
NCT03600259 -
Tianjin Inpatient Acute Myocardial Infarction Registry
|
||
| Active, not recruiting |
NCT03441724 -
Mechanocardiography in Patients With STEMI
|